Why Does A Genetically Normal Embryo Fail To Implant? By manara99 on March 12, 2016

In recent years we have developed technology that enables us to determine if an embryo is genetically normal before it is transferred to the uterus. Various technologies are available toanalyze cells taken from the embryo at the blastocyst stage of development and these technologies continue to become more sensitive and comprehensive. With the ability to confidently transfer genetically normal (euploid) embryos, our expectations for successful implantation are high. However, in spite of the application of this technology, a substantial number of these embryos fail to result in a live birth and we are left with the task of understanding these failures and explaining them to our patients.


A recent article by Dr. David Meldrum published in Fertility and Sterility (March, 2016) addresses this question and provides potential explanations for these failures. Dr. Meldrum suggests the following interesting and provocative thoughts on this subject:


1) The egg is a very large cell and it is possible that the cytoplasm is more important than the

nucleus. The cytoplasm of the embryo may not be sufficient to support a fully capable



2) Environmental influences such as smoking and obesity may negatively influence the quality of the egg, and later the embryo. The available data suggest that a 3-6 month recovery period may be necessary to overcome the effects of these environmental influences on egg cytoplasm.


3) Male hormones (androgens) play an important role in achieving competence of the egg and

it is well understood that androgen levels wane with advancing age. The use of androgen

supplements such as DHEA (dehydroepiandrosterone) to overcome this adverse influence

on the egg seem to require 2 to 3 months to be effective. Mild stimulation of the ovary with

low dose testosterone requires about 3 weeks to achieve a benefit.


4) Mitochondria within the egg are critical for chromosome division and cell division especially

in the early days of embryo development. CoQ 10 has been proven to improve

mitochondrial activity in animal models and has been advocated as one method of

improving mitochondrial energy in the egg after at least 2 months of supplementation.


5) Emotional stress leading to the "fight or flight" response may improve blood flow to the vital

organs such as the heart and lungs, while diverting blood from the nonessential organs such

as the ovary. Mind-body programs aimed at reducing stress may be beneficial.


6) Some investigators have associated poor outcomes in older patients with the use of high

doses of pituitary hormones. While it is tempting to use more and more medication to

stimulate greater numbers of eggs to maturity, this may not be the best strategy for obtaining

the best quality eggs especially for our older patients.


7) Growth hormone levels are known to fall as women age and low growth hormone levels

within the ovarian follicles are associated with poor IVF pregnancy rates. It may be that

growth hormone plays an important part in preparing egg cytoplasm for early embryo



8) In has been observed that there should be a natural surge in FSH at the time of the LH

surge. However, since the earliest days of IVF, HCG has replaced the LH surge.

The HCG trigger shot seems to eliminate the FSH surge. It has been suggested that

restoration of the FSH surge might improve the quality of the egg and early embryo.


9) Optimization in the IVF laboratory including culturing in low oxygen environment,

optimization of culture media, possibly co-culture, and the use of bench top incubators that

recover more quickly after opening and closing.


10) Embryo biopsy techniques need to be optimized in order to minimize the impact on the

developing embryo.


11) Each individual patient may have their own unique window of endometrial receptivity and

technologies are being developed to identify the precise window of receptivity on an

individual basis. This approach may be an important method to improve IVF live birth rates

and decrease failure rates especially when transferring genetically normal embryos.


Since the first IVF success in 1978, we have witnessed slow and steady improvements in treatment outcomes.  With each step forward, new challenges invariably arise as we strive to create and identify the ideal embryo and place it in the optimal uterine environment.  This blog post reviews the thoughts of Dr. David Meldrum, one of the most recognized and respected leaders in our profession.

Related to This

Dr. Louis R. Manara

Center for Reproductive Medicine and Fertility

Dr. Louis R. Manara and the Center for Reproductive Medicine and Fertility team are dedicated to helping families achieve parenthood through safe, versatile, and personalized treatment options. We are affiliated with several noteworthy organizations including:

  • American Society for Reproductive Medicine
  • Society for Assisted Reproductive Technology
  • American Osteopathic Association®

​If you are struggling with infertility, a professional diagnosis is the best way to explore your treatment options. Schedule your initial consultation today by contacting us online or calling us at (856) 767-0009.

Contact Us Today

Rate, Review & Explore

Social Accounts Sprite